RE:RE:TD 2I'm not sure I agree, they don't intend on spinning out and liquiditating. They were very clear on retaining a strong majority and continuing to operate and benefit from having the tech available to them. It seems like they are doing this to create a clear valuation profile for something that is currently hidden by all the clinical revenues. It also helps them create stock value that they can use to buy companies with. Actually seems smart and doesn't sound like a shift of the goal posts at all.